The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2029

Study Completion Date

October 31, 2030

Conditions
Colorectal AdenomaProbiotics
Interventions
DRUG

Clostridium butyricum capsules, Live

Oral Clostridium butyricum capsules, Live: take 3 capsules twice daily (bid) for the first 3 months after adenoma resection, then continue with 3 capsules once daily (qd) until 3 years post-resection (each capsule contains ≥6.3 × 10⁶ CFU of Clostridium butyricum).

OTHER

Control (placebo)

Placebo capsules containing corn starch, with identical appearance, weight, and administration method as the treatment group.

Trial Locations (1)

266000

the Affiliated Hospital of QIngdao University, Qingdao

All Listed Sponsors
collaborator

Shandong Provincial Hospital

OTHER_GOV

collaborator

Linyi People's Hospital

OTHER

collaborator

Shandong Cancer Hospital and Institute

OTHER

collaborator

Yantai Yuhuangding Hospital

OTHER

collaborator

Jining First People's Hospital

OTHER

collaborator

Rizhao People's Hospital

OTHER

collaborator

Qianfoshan Hospital

OTHER

collaborator

Weifang People's Hospital

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Taian City Central Hospital

OTHER

collaborator

The Affiliated Hospital of Shandong Second Medical University

UNKNOWN

collaborator

Dongying People's Hospital

OTHER

lead

The Affiliated Hospital of Qingdao University

OTHER